$OFRM

Once Upon a Farm, PBC (OFRM): Results of Operations and Financial Condition

Once Upon a Farm, PBC (OFRM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ofrm-ex99_1.htm EX-99.1 EX-99.1 Once Upon a Farm Reports Second Quarter 2026 Financial Results Second quarter net sales increased 42% year-over-year to $85 million Raising 2026 net sales outlook to $327 million to $335 million Raising 2026 Adjusted EBITDA outlook to $3

Original reporting
Published Aug 6, 2026, 8:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$OFRM
Bullish
medium confidence
Mentioned
$OFRM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OFRMBullishHigh
01

Why it matters

The key tradable items are the Q2 operating metrics (sales growth, margin compression, net loss improvement) and the raised 2026 guidance for both net sales and Adjusted EBITDA, plus the balance sheet shift to higher cash and no debt post-IPO proceeds.

02

Market read

Guidance raise plus improved loss profile can drive near-term repricing, while margin and expense dynamics set up debate on profitability path.

03

What to watch

Investors may scrutinize the quality of Adjusted EBITDA (non-GAAP adjustments) and the sustainability of cooler productivity and trade spend assumptions behind the outlook.

Relevance 7/10Novelty 9/10Timing: after-hours today, with a live earnings call scheduled for 5:00 pm ET

Background

This is an SEC Form 8-K with the company’s Q2 2026 results and full-year 2026 outlook update.

Company-level read

Ticker impact

$OFRMBullishMedium confidence
Context

Once Upon a Farm reported Q2 net sales up 42.3% to $85.4M and raised 2026 net sales to $327M-$335M and Adjusted EBITDA to $3M-$4.5M.

Expected impact

Likely positive near-term bias as the guidance raise can re-rate growth expectations, though investors may focus on gross margin decline and higher SG&A.

Evidence & confidence

The filing includes explicit Q2 results and a same-day upward revision to both revenue and Adjusted EBITDA, which are direct valuation drivers. Offsetting factors include a 485 bps gross margin decline and higher SG&A as a percent of sales.

Market effects

Supports sentiment for high-growth organic kids food brands by showing distribution expansion and incremental innovation contributing to consumption.

No clear regional spillover beyond US-listed consumer/food growth narrative.

Limited, as the disclosure is company-specific and not tied to global macro or international regulatory actions.

Counterpoint

The gross margin fell 485 bps and SG&A rose sharply as a percent of sales, so the guidance raise may rely on continued scale benefits that could be harder to sustain.

Key entities

  • Once Upon a Farm, PBC

    NYSE-listed organic kids’ food company reporting Q2 2026 results and raising full-year guidance.

  • John Foraker

    CEO and co-founder quoted on growth drivers and the rationale for the outlook raise.

Related articles

$OFRMMedAI 8/10

Once Upon a Farm Lifts 2026 Outlook Again as Q2 Revenue Surges 42%

Once Upon a Farm (NYSE: OFRM) reported Q2 2026 net sales up more than 42% year over year to $85.4 million, beating expectations, and raised full-year revenue guidance for a second straight quarter. The company now forecasts 2026 net sales of $325 million to $335 million, citing continued distribution expansion and growth in baby and kids categories.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.